Anticipated and unanticipated consequences of abuse deterrent formulations of opioid analgesics

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1557|24|2|205-207

ISSN： 1053-8569

Source： PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol.24, Iss.2, 2015-02, pp. : 205-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of abuse‐deterrent OxyContin on prescription opioid utilization

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 2, 2015-02 ,pp. : 197-204

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended‐Release Oxycodone Formulations with Abuse‐Deterrent Properties

By  

PAIN MEDICINE, Vol. 16, Iss. 11, 2015-11 ,pp. : 2142-2151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of Opioid Analgesics in Older Australians

By  

PAIN MEDICINE, Vol. 16, Iss. 8, 2015-08 ,pp. : 1519-1527

John Wiley & Sons Inc

Access to resources Recommend Favorite

FDA issues final guidance on abuse‐deterrent opioids

By  

ALCOHOLISM AND DRUG ABUSE WEEKLY, Vol. 27, Iss. 15, 2015-04 ,pp. : 6-6

John Wiley & Sons Inc

Access to resources Recommend Favorite

FDA issues final guidance on abuse‐deterrent opioids

By  

THE BROWN UNIVERSITY CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY UPDATE, Vol. 17, Iss. 5, 2015-05 ,pp. : 8-8

John Wiley & Sons Inc

Access to resources Recommend Favorite